Page 3 - Loncode Institute News Today

Investegate announcements from Jeito Capital, Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics

Jeito Capital demonstrates European biopharma leadership with first exit with AstraZeneca acquisition of Neogene Therapeutics Deal

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

The firm will use the money to advance its tumor organoid platform, which can be used for precision oncology drug discovery and for guiding treatment decisions.

Hormone therapy can keep metastatic prostate cancer well under control, but sooner or later tumor cells become resistant to it. Unexpectedly, a possible solution has now emerged: drugs that are not designed to fight cancer at all, but which influence

In a study of prostate cancer, researchers found that tumors used proteins to hijack our circadian day-and-night rhythm and decrease the effects of anti-hormonal therapy.

Lixte Biotechnology (NASDAQ:LIXT – Get Rating) is one of 941 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare Lixte Biotechnology to similar businesses based on the strength of its profitability, earnings, dividends, institutional ownership, valuation, analyst recommendations and risk. Insider and Institutional Ownership 8.8% of […]

Why doesn't every cancer patient respond to immunotherapy? That's the question that researcher Daniel Peeper is looking to answer.

Lixte Biotechnology (NASDAQ:LIXT – Get Rating) is one of 941 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its peers? We will compare Lixte Biotechnology to related companies based on the strength of its institutional ownership, valuation, earnings, analyst recommendations, dividends, risk and profitability. Analyst Ratings This is […]

In PLOS this week: variants linked to perceived quality of life during the pandemic, atrial fibrillation meta-analysis, and more.